glp-1 consumer brands news Alarming rise in weight loss drug overdoses Drugmaker warns copycat GLP-1 drugs

[DOI] [PubMed] [Google Scholar] 128

Brown JD, Buscemi J, Milsom V, Malcolm R, ONeil PM

A doctor who understands eating disorder history should be part of the prescribing team

Back Brown, JC, Magee, DF (Feb 1967) 'Inhibitory action of cholecystokinin on acid secretion from Heidenhain pouches induced by endogenous gastrin', Gut , 8/1, 29-31

McGraw-Hill / Lange rxlist.com (Januvia ) Keywords Saxagliptin Trade Name: Onglyza Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: mixed renal & hepatic clearance dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)